Wang Yao, Xu Kun, Zhang Hongbing, Zhao Junhong, Zhu Xiuping, Wang Yangzheng, Wu Renyi
Eye Institute and Affiliated Xiamen Eye Center, Xiamen University, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, P.R. China.
Department of Ophthalmology, First Hospital of Xi'an, Shaanxi Institute of Ophthalmology, Shaanxi Provincial Key Laboratory of Ophthalmology, Xi'an, Shaanxi 710002, P.R. China.
Mol Med Rep. 2014 Sep;10(3):1179-83. doi: 10.3892/mmr.2014.2346. Epub 2014 Jun 19.
Accumulative evidence has indicated that apoptosis is the common pathway for retinal ganglion cell (RGC) death and that autophagy promotes survival of RGCs in glaucoma. In the present review, it was hypothesized that the progressive death of RGCs in glaucoma involves another novel non‑apoptotic programmed cell death, known as 'paraptosis', in the early stages of glaucoma. Paraptosis may be accompanied by apoptosis and/or autophagy in the moderate and severe stages. The secondary hypothesis suggests that paraptosis in glaucomatous RGCs may be triggered by damage to cellular mitochondria, and is associated with mitochondria-derived reactive oxygen species (ROS). Our preliminary laboratory studies, using transmission electron microscopy, provided evidence that supports the primary hypothesis. The secondary hypothesis is currently under investigation. These two hypotheses provide a novel way to investigate the mechanisms of cell death in glaucomatous RGCs and targeting paraptosis may be a promising strategy for RGC-protecting drug discovery.
越来越多的证据表明,细胞凋亡是视网膜神经节细胞(RGC)死亡的常见途径,而自噬可促进青光眼患者RGC的存活。在本综述中,我们推测青光眼患者RGC的渐进性死亡在青光眼早期涉及另一种新的非凋亡程序性细胞死亡,即“副凋亡”。在中度和重度阶段,副凋亡可能伴有细胞凋亡和/或自噬。第二个假说是,青光眼性RGC中的副凋亡可能由细胞线粒体损伤触发,并与线粒体衍生的活性氧(ROS)有关。我们使用透射电子显微镜进行的初步实验室研究提供了支持第一个假说的证据。第二个假说目前正在研究中。这两个假说为研究青光眼性RGC的细胞死亡机制提供了一种新方法,针对副凋亡可能是发现RGC保护药物的一个有前景的策略。